The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research.
However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
Patient Story. She had large B-cell lymphoma β an aggressive cancer diagnosed in , patients each year globally. Four years later the lymphoma returned. Robyn entered remission again, but it was short-lived, with the lymphoma returning nine months later. Treatment options for Robyn were now bleak and limited. Our cell and gene therapy specialists collaborate to help get your innovative treatments to patients like Robyn faster. He reinforces our patient-first focus to help ensure your trials are designed to meet patient needs.
Our diverse experiences ensure you get the expertise you need, no matter the indication. Our experience with CAGT clinical trial sites around the world allows us to accelerate study start-ups.
Access to global EMR data enables us to pinpoint the perfect sites for your trial. Our cross-functional team overcomes any technical, logistical, and strategic challenges. Our highly tailored recruitment and retention strategies drive access to even hard-to-find patient populations.
